ライフサイエンスコーパス: cell adhesion molecule-1

1 PF-00547659 (anti-mucosal vascular addressin cell adhesion molecule 1).

2 ate antigen 4 binding to its ligand vascular cell adhesion molecule 1.

3 leukin 1beta, interferon gamma, and vascular cell adhesion molecule 1.

4 g with soluble and immobilized intercellular cell adhesion molecule 1.

5 for the vascular marker platelet endothelial cell adhesion molecule 1.

6 lial activation, angiopoietin 2 and vascular cell adhesion molecule 1.

7 ring within focal adhesive sites on vascular cell adhesion molecule-1.

8 monocyte chemotactic protein-1, and vascular cell adhesion molecule-1.

9 rosis factor-mediated expression of vascular cell adhesion molecule-1.

10 cle cell actin and up-regulation of vascular cell adhesion molecule-1.

11 IL-6, serum amyloid P, and soluble vascular cell adhesion molecule-1.

12 de mimicking monocyte engagement by vascular cell adhesion molecule-1.

13 1 and loss of binding to its ligand vascular cell adhesion molecule-1.

14 ] vs. 1.66 [1.22-2.63] p < 0.0001), vascular cell adhesion molecule 1 (539 [451-621] vs. 402 [342-487

15 tein-1 (-13% versus +0.2%), soluble vascular cell adhesion molecule-1 (-6% versus +1%), high-sensitiv

16 Tumour necrosis factor alpha, vascular cell adhesion molecule-1, 8-isoprostane, leptin, circula

17 of CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), a transmembrane glycoprotein

18 Vascular cell adhesion molecule 1, an adhesion molecule that medi

19 ed monocyte adhesion by attenuating vascular cell adhesion molecule -1 and monocyte chemoattractant p

20 hesion to their respective ligands, vascular cell adhesion molecule 1 and intercellular adhesion mole

21 k of vessels expressing platelet/endothelial cell adhesion molecule 1 and vascular endothelial growth

22 their respective ligands, mucosal addressin cell adhesion molecule-1 and CCL25, are displayed on end

23 g in increased adhesion to mucosal addressin cell adhesion molecule-1 and enhanced homing to Peyer's

24 ls adhere to high concentrations of vascular cell adhesion molecule-1 and intercellular adhesion mole

25 ecreased collar-induced endothelial vascular cell adhesion molecule-1 and intercellular adhesion mole

26 vels and inhibited cytokine-induced vascular cell adhesion molecule-1 and intercellular adhesion mole

27 ice showed significant decreases in vascular cell adhesion molecule-1 and intercellular adhesion mole

28 In addition, CLP-increased vascular cell adhesion molecule-1 and intercellular adhesion mole

29 and increased plasma levels of intercellular cell adhesion molecule-1 and monocyte chemoattractant pr

30 and plasma adhesion molecules, intercellular cell adhesion molecule-1 and monocyte chemoattractant pr

31 for inflammatory mediators such as vascular cell adhesion molecule-1 and monocyte chemotactic protei

32 he expression of adhesion molecules vascular cell adhesion molecule-1 and monocyte chemotactic protei

33 Whereas vascular cell adhesion molecule-1 and P-selectin were not require

34 ascular adhesion molecules, such as vascular cell adhesion molecule-1 and platelet endothelial cell a

35 nd endothelial dysfunction (soluble vascular cell adhesion molecule-1 and soluble intercellular adhes

36 ted adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 and the fibronectin spliceoform

37 ination by increasing expression of vascular cell adhesion molecule-1 and the transcytosis protein Ca

38 overy in the absence of platelet endothelial cell adhesion molecule-1 and the tyrosine phosphatase CD

39 s interactions with both macrophage Vascular Cell Adhesion Molecule-1 and with extracellular matrix f

40 mor necrosis factor alpha receptor, vascular cell adhesion molecule 1, and matrix metalloproteinase 2

41 rkers (CD34, endomucin, platelet endothelial cell adhesion molecule 1, and plasmalemmal vesicle-assoc

42 intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and tissue factor messenger RN

43 e measured levels of hsCRP, ICAM-1, vascular cell adhesion molecule 1, and tumor necrosis factor alph

44 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expressions are

45 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin.

46 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and leptin and decreased inter

47 igh-mobility group protein B1, intracellular cell adhesion molecule-1, and leptin, as well as previou

48 intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and monocyte chemotactic prote

49 sion molecule (VCAM)-1, platelet-endothelial cell adhesion molecule-1, and P-selectin and L-selectin

50 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and VEDS probands had abnormal

51 intravenously injected antibody to vascular cell adhesion molecule 1 (anti-VCAM) in the inflamed bra

52 function blocking anti-platelet endothelial cell adhesion molecule 1 antibody, depolymerizing microt

53 s vascular ligand mucosal vascular addressin cell adhesion molecule 1 are proving the value of lympho

54 Here, we identify vascular cell adhesion molecule 1 as the relevant receptor for ly

55 ds to reduced levels of platelet endothelial cell adhesion molecule-1 at the cell surface.

56 ted adhesion of proerythroblasts to Vascular Cell Adhesion Molecule-1 but not to the fibronectin spli

57 12% (95% CI, -14% to -10%), soluble vascular cell adhesion molecule-1 by 14% (95% CI, -18% to -10%),

58 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by, and adhesion of human eosin

59 Human carcinoembryonic antigen-related cell adhesion molecule 1 (C?/Au: EACAM1) is a cell-surfa

60 ns between body mass index and two loci near cell adhesion molecule 1 (CADM1) and cell adhesion molec

61 says to establish that the tumour suppressor Cell adhesion molecule 1 (CADM1) inhibits SqCC prolifera

62 pon activation, whereas the ligand of Crtam, cell adhesion molecule 1 (Cadm1), is expressed on gut CD

63 neutralization of stem cell factor (SCF) or cell adhesion molecule 1 (CADM1).

64 We have investigated the role of cell adhesion molecule 1 (Cadm1; Necl2) in this disease.

65 partially dependent on adhesion mediated by cell adhesion molecule-1 (CADM1), but the adhesion mecha

66 -1 increased eosinophil adhesion to vascular cell adhesion molecule-1, caused redistribution of integ

67 lar adhesion molecule 2 (CD102) and vascular cell adhesion molecule 1 (CD106).

68 A1, we detected reduced platelet endothelial cell adhesion molecule 1 (CD31) and increased endothelia

69 ine kinase 7 (PTK7) and platelet endothelial cell adhesion molecule-1 (CD31).

70 ults showed that carcinoembryonic Ag-related cell adhesion molecule 1 (CEACAM-1), a molecule expresse

71 ntify the NET-associated carcinoembryonic Ag cell adhesion molecule 1 (CEACAM1) as an essential eleme

72 The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) can engage in both ci

73 with absent carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) exhibited increased i

74 ion between carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression and malign

75 hough carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1) has been viewed as a

76 ole for the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in the regulation of

77 The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a transmembrane gl

78 Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is expressed at high

79 Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) promotes hepatic insu

80 Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) regulates insulin sen

81 a heterodimer with carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1), another well-known m

82 ptor murine carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), which surprisingly r

83 on molecule carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1-S) in which G-actin bi

84 Although carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is an activation mark

85 Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is expressed in a var

86 Carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1), a transmembrane prot

87 thelial activation markers (soluble vascular cell adhesion molecule-1) decreased but remained elevate

88 tercellular adhesion molecule 1 and vascular cell adhesion molecule 1, disruption or loosening of adh

89 Neurons that lack Drosophila Down syndrome cell adhesion molecule 1 (Dscam1) show aberrant overlap,

90 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, endothelial selectin, and angi

91 y important regulatory proteins, endothelial cell adhesion molecule 1 (ESAM1) and cadherin 5 (CDH5),

92 e posttranscriptional regulation of vascular cell adhesion molecule 1 expression and a reduced number

93 ted with a marked reduction in lung vascular cell adhesion molecule 1 expression and production of se

94 BD-E2 rats exhibited a reduction in vascular cell adhesion molecule 1 expression and reduced cytokine

95 dhesion molecule 1, and platelet endothelial cell adhesion molecule 1 expression when stimulated with

96 criptional activity and upregulated vascular cell adhesion molecule 1 expression.

97 ercellular adhesion molecule 1, and vascular cell adhesion molecule 1 expression; and (e) ELISA for c

98 markers, and carotid P-selectin and vascular cell adhesion molecule-1 expression by contrast-enhanced

99 Furthermore, vascular cell adhesion molecule-1 expression in both mouse and hu

100 uperoxide production, and increased vascular cell adhesion molecule-1 expression in human aortic endo

101 y, CPAP-30 and STEP-30/30 increased vascular cell adhesion molecule-1 expression, but the type of rec

102 thelial ROS production, endothelial vascular cell adhesion molecule-1 expression, matrix metalloprote

103 was associated with an increase in vascular cell adhesion molecule-1 expression, which itself was re

104 d with beta-blocker showed enhanced vascular cell adhesion molecule-1 expression.

105 sphorylated beta-catenin stimulates vascular cell-adhesion molecule-1 expression to increase EC-monoc

106 ed strong CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) expression by neoplastic cells

107 tracellular adhesion molecule 1 and vascular cell adhesion molecule 1) genes involved in myeloid cell

108 ed in wildtype mice, glycosylation-dependent cell adhesion molecule 1 (Glycam1), expressed 7-fold hig

109 necrosis factor receptor-1, soluble vascular cell adhesion molecule-1, granulocyte colony-stimulating

110 , and induced up-regulation of intercellular cell adhesion molecule-1, HLA-DR, and CD40 by primary ep

111 , and ultimately for promoting intracellular cell adhesion molecule 1 (ICAM-1) binding.

112 sion by T cells, chemokine and intracellular cell adhesion molecule 1 (ICAM-1) expression in the brai

113 various methods, we found that intercellular cell adhesion molecule 1 (ICAM-1) was reduced in Lec9 ce

114 ulates the lateral mobility of intracellular cell adhesion molecule 1 (ICAM-1), but not MHCII.

115 inflammation (p65, caspase 1, VCAM [vascular cell adhesion molecule-1], ICAM [intercellular adhesion

116 (ie, ET-1, ET-A and ET-B receptors, vascular cell adhesion molecule-1, IL-6, and fractalkine) is part

117 tion of VE-cadherin and platelet endothelial cell adhesion molecule 1, impaired development of baseme

118 cells; IL-4; IL-5; eosinophils, and vascular cell adhesion molecule 1 in the large airways and bronch

119 ocyte chemoattractant protein-1 and vascular cell adhesion molecule 1 in wire-injured carotid arterie

120 tores the expression of platelet endothelial cell adhesion molecule-1 in glomerular endothelial cells

121 ncrease in plasma levels of soluble vascular cell adhesion molecule-1 in sickle mice was not mediated

122 l adhesion molecules E-selectin and vascular cell adhesion molecule-1 in the microvasculature of kidn

123 elial nitric oxide, superoxide, and vascular cell adhesion molecule-1 in vitro improved significantly

124 on and enhanced binding to mucosal addressin cell adhesion molecule-1 in vitro while simultaneously s

125 n vitro and increased expression of vascular cell adhesion molecule-1 in vivo.

126 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1) in 524 middle-aged women in th

127 racellular adhesion molecule 1, and vascular cell adhesion molecule 1), increased expression of CB(1)

128 (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), inducible nitric oxide syntha

129 intercellular adhesion molecule-1, vascular cell adhesion molecule-1, inducible nitric oxide synthas

130 illebrand factor (VWF), E-selectin, vascular cell adhesion molecule 1, intercellular adhesion molecul

131 dothelial growth factor receptor-2, vascular cell adhesion molecule 1, intercellular adhesion molecul

132 wnregulated the local expression of vascular cell adhesion molecule-1, intercellular adhesion molecul

133 asing the expression of E-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecul

134 Plasminogen activator inhibitor 1, vascular cell adhesion molecule-1, intracellular adhesion molecul

135 Platelet-endothelial cell adhesion molecule-1 is a transmembrane protein conn

136 e cell adhesion protein platelet endothelial cell adhesion molecule-1 is dependent on the protein acy

137 pression of 194 genes, such as claudin 3 and cell adhesion molecule 1, is significantly decreased.

138 NF-kappaB activation also induced vascular cell adhesion molecule 1, keratinocyte chemoattractant,

139 nes, leukotriene B(4) (LTB(4)), and vascular cell adhesion molecule 1 levels in the lungs, was reduce

140 , neuron-specific enolase, and intracellular cell adhesion molecule-1 levels did not differ between n

141 derived microparticles, platelet-endothelial cell adhesion molecule-1 lung protein content, and immun

142 ruptions in positioning of mucosal addressin cell adhesion molecule 1 (MAdCAM-1)(+) sinus lining cell

143 rned to display dominantly mucosal addressin cell adhesion molecule 1 (MAdCAM-1).

144 ssion patterns of mucosal vascular addressin cell adhesion molecule-1 (MAdCAM-1) and T cell responses

145 adhesion molecule mucosal vascular addressin cell adhesion molecule-1 (MAdCAM-1) and that RA increase

146 promotes cell adherence to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expressed by vascula

147 tibody that binds to human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to selectively reduc

148 al ligand for alpha4beta7, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), bound efficiently t

149 of endothelial absence of mucosal addressin cell-adhesion molecule-1 (MAdCAM-1), which was also coup

150 ntibodies against mucosal vascular addressin cell adhesion molecule 1 (MADCAM1), which is capable of

151 n humans as XCR1(+)CD141 (BDCA-3)(+)Clec9A(+)cell adhesion molecule 1(+) mDC, and in sheep as CD26(+)

152 me-controlled ventilation increased vascular cell adhesion molecule-1 messenger RNA expression (volum

153 pendent on Schwann cell expression of neural cell adhesion molecule 1 (NCAM1) and ultimately promoted

154 We also found that miR-200c and neural cell adhesion molecule 1 (NCAM1) expression were negativ

155 Neural cell adhesion molecule 1 (NCAM1; CD56) is expressed in u

156 rly AMD was associated with soluble vascular cell adhesion molecule-1 (odds ratio per SD on the logar

157 onic PTSD had a greater increase in vascular cell adhesion molecule-1 over time (B = 0.003, p < .05).

158 the endothelial activation markers vascular cell adhesion molecule 1 (P < .001 for both) and angiopo

159 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1 (P < .05).

160 dhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 (P < 0.05 above bacterial load

161 ted levels of NT-proBNP and soluble vascular cell adhesion molecule-1 (P< .001).

162 muscle actin, vimentin, platelet endothelial cell adhesion molecule 1 (PECAM), and aquaporin 1, a mar

163 Using platelet endothelial cell adhesion molecule 1 (PECAM-1) as a prototypical ITI

164 ated with antibodies to platelet/endothelial cell adhesion molecule 1 (PECAM-1) bind specifically to

165 regulation of MHC-I and platelet endothelial cell adhesion molecule 1 (PECAM-1) but not other substra

166 steocalcin, Vega-a, and platelet endothelial cell adhesion molecule 1 (PECAM-1) in Fgf-9(+/-) defects

167 Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1) is a major component

168 Platelet endothelial cell adhesion molecule 1 (PECAM-1) is involved in leukoc

169 on molecule 1 (VCAM-1), platelet-endothelial cell adhesion molecule 1 (PECAM-1), CD99, and interleuki

170 tioning in part through platelet endothelial cell adhesion molecule 1 (PECAM-1), drives advanced meta

171 ntegrins and recognizes platelet endothelial cell adhesion molecule 1 (PECAM-1), suggesting a role in

172 continuous detection of platelet endothelial cell adhesion molecule 1 (PECAM-1)-dependent, outside-in

173 dent firm adhesion, and platelet/endothelial cell adhesion molecule 1 (PECAM-1)-mediated transendothe

174 cells, colocalizes with platelet/endothelial cell adhesion molecule-1 (PECAM) to surround leukocytes

175 ion molecules including Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1 or CD31) improves drug

176 beta-toxin (CPB) binds platelet endothelial cell adhesion molecule-1 (PECAM-1) (also known as CD31)

177 se in the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) and a decrease in the

178 se in the expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) and a decrease in the

179 Platelet endothelial cell adhesion molecule-1 (PECAM-1) and heterotrimeric G

180 Platelet-endothelial cell adhesion molecule-1 (PECAM-1) and the Src family ki

181 otransducers, including platelet endothelial cell adhesion molecule-1 (PECAM-1) at cell-cell junction

182 a, as well as increased platelet endothelial cell adhesion molecule-1 (PECAM-1) expression, which was

183 Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a 130-kDa member o

184 cule (MCAM)/MUC18, CD31/platelet endothelial cell adhesion molecule-1 (PECAM-1), CD144/VE-cadherin, a

185 One CAM member, platelet-endothelial-cell adhesion molecule-1 (PECAM-1), plays an important r

186 chanosensors, including platelet endothelial cell adhesion molecule-1 (PECAM-1), that convert mechani

187 ion of the shear sensor platelet endothelial cell adhesion molecule-1 (PECAM-1).

188 urface targets like the Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1, a highly expressed en

189 inished inflammation (expression of vascular cell adhesion molecule 1, plaque macrophage content) and

190 adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 post-IRI.

191 the stromal cells and with reduced vascular cell adhesion molecule 1 production by them.

192 cles and a reduction of platelet-endothelial cell adhesion molecule-1 protein levels in the high-tida

193 tercellular adhesion molecule 1 and vascular cell adhesion molecule-1 rather than endothelial cells w

194 ering to culture plates coated with vascular cell adhesion molecule 1, SDF-1 and stem cell factor inc

195 l-derived von Willebrand factor and vascular cell adhesion molecule 1, sensitizes DTCs to chemotherap

196 inally associated with soluble intracellular cell adhesion molecule-1 (sICAM-1) (P = 0.026) and TNF-R

197 esion molecule 1 (sICAM-1), soluble vascular cell adhesion molecule 1, soluble E-selectin, and monocy

198 llular adhesion molecule-1, soluble vascular cell adhesion molecule-1, soluble E-Selectin, and P-Sele

199 fms-like tyrosine kinase-1, soluble vascular cell adhesion molecule-1, soluble intercellular adhesion

200 n), and leukocyte adhesion (soluble vascular cell adhesion molecule-1, soluble intracellular adhesion

201 tercellular adhesion molecule-1 and vascular cell adhesion molecule-1 surface expression in BMVECs ex

202 pancreatic cancer and found soluble vascular cell adhesion molecule-1 (sVCAM-1) increases in response

203 Soluble vascular cell adhesion molecule-1 (sVCAM-1) is a marker of endoth

204 r adhesion molecule-1 (sICAM-1) and vascular cell adhesion molecule-1 (sVCAM-1) were higher following

205 ular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-Selec

206 zed the synapse-organizing proteins Synaptic Cell Adhesion Molecule 1 (SynCAM 1) and EphB2.

207 for NCAM, neuropilin-2 (NRP-2), and synaptic cell adhesion molecule 1 (SynCAM 1) for polysialylation

208 Among them is synaptic cell adhesion molecule 1 (SynCAM 1), a member of the imm

209 Here we identify that the synaptic cell adhesion molecule 1 (SynCAM 1), an immunoglobulin s

210 lect adhesion molecules such as the Synaptic Cell Adhesion Molecule 1 (SynCAM 1/CADM1/nectin-like 2 p

211 endothelial expression of mucosal addressin cell adhesion molecule-1, the ligand that supports entry

212 tercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1, thereby amplifying leukocyte t

213 eptor 2, interleukin-6, and soluble vascular cell adhesion molecule-1 to the 20-year cumulative incid

214 suggest that lymphocyte binding to vascular cell adhesion molecule 1 triggers a signaling process th

215 (intercellular adhesion molecule-1, vascular cell adhesion molecule-1), tumor necrosis factor-alpha,

216 including VE-cadherin, platelet endothelial cell adhesion molecule 1, type IV collagen, matrix metal

217 dramatically increased platelet-endothelial cell adhesion molecule 1 tyrosine phosphorylation and di

218 tercellular adhesion molecule 1 and vascular cell adhesion molecule 1 under the migrating leukocyte,

219 rkers (Flk1, Tal1/Scl1, platelet endothelial cell adhesion molecule 1, vascular endothelial-cadherin,

220 ess to alpha4beta1 integrin ligands vascular cell adhesion molecule 1 (VCAM-1) and fibronectin, where

221 The levels of soluble vascular cell adhesion molecule 1 (VCAM-1) and osteoprotegerin we

222 vealed that the interaction between vascular cell adhesion molecule 1 (VCAM-1) and very late antigen-

223 ted to the lungs via RAGE-dependent vascular cell adhesion molecule 1 (VCAM-1) expression on lung end

224 Vascular cell adhesion molecule 1 (VCAM-1) expression, however, w

225 ar adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in the lungs of infect

226 red by binding of beta1-integrin to vascular cell adhesion molecule 1 (VCAM-1) on neurons in the infl

227 Vascular cell adhesion molecule 1 (VCAM-1) plays a major role in

228 cyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflame

229 lical vein endothelial cell (HUVEC) vascular cell adhesion molecule 1 (VCAM-1) upregulation.

230 Levels of vascular cell adhesion molecule 1 (VCAM-1) were measured by sandw

231 Here, we show that red pulp vascular cell adhesion molecule 1 (VCAM-1)(+) macrophages are ess

232 as an adhesive ligand that captures vascular cell adhesion molecule 1 (VCAM-1)(+) metastatic tumor ce

233 d antibody (pro-antibody) targeting vascular cell adhesion molecule 1 (VCAM-1), a marker of atheroscl

234 pression of an inflammatory marker, vascular cell adhesion molecule 1 (VCAM-1), in atherosclerotic pl

235 adherence to endothelium, including vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesio

236 lular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), platelet-endothelial

237 ent directed against mouse or human vascular cell adhesion molecule 1 (VCAM-1), recently has been pro

238 chemoattractant protein 1 (MCP-1), vascular cell adhesion molecule 1 (VCAM-1), secretory phospholipa

239 llular adhesion molecule 1 (ICAM-1)/vascular cell adhesion molecule 1 (VCAM-1)-mediated adhesion of b

240 as specific for L-selectin, because vascular cell adhesion molecule 1 (VCAM-1)-mediated adhesion was

241 ve behavioral outcomes, and a novel vascular cell adhesion molecule 1 (VCAM-1)-targeted magnetic reso

242 ar adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1).

243 ion molecules (ELAM) E-selectin and vascular cell adhesion molecule 1 (VCAM-1).

244 Vascular cell adhesion molecule 1 (VCAM-1; CD106), a member of th

245 In vivo molecular imaging of vascular cell adhesion molecule-1 (VCAM 1) P-selectin, and platel

246 p II: 0.14 (0.20) mug/mL, P = .02); vascular cell adhesion molecule-1 (VCAM-1) (Group I: 0.34 (0.67)

247 Binding of leukocytes to vascular cell adhesion molecule-1 (VCAM-1) activates signals in e

248 bition of TNF-induced expression of vascular cell adhesion molecule-1 (VCAM-1) and could be mimicked

249 an PDEs of the endothelial proteins vascular cell adhesion molecule-1 (VCAM-1) and endothelial nitric

250 g-induced endothelial expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhe

251 ing that controls expression of the vascular cell adhesion molecule-1 (VCAM-1) and monocyte adhesion

252 ll as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemotact

253 the endothelial activation markers vascular cell adhesion molecule-1 (VCAM-1) and vascular adhesion

254 ished by CD29 blockade on hMSCs and vascular cell adhesion molecule-1 (VCAM-1) blockade on HSECs.

255 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression by redox-de

256 treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in a PKCeps

257 Vascular cell adhesion molecule-1 (VCAM-1) expression was notable

258 lammation was used to induce global vascular cell adhesion molecule-1 (VCAM-1) expression.

259 o transiently augmented LPS-induced vascular cell adhesion molecule-1 (VCAM-1) expression.

260 l presents additional evidence that vascular cell adhesion molecule-1 (VCAM-1) imaging in atheroscler

261 target genes tissue factor (TF) and vascular cell adhesion molecule-1 (VCAM-1) in diabetic apoE(-/-)h

262 enesis, but increased expression of vascular cell adhesion molecule-1 (VCAM-1) in primary culture of

263 Vascular cell adhesion molecule-1 (VCAM-1) is expressed on the me

264 Vascular cell adhesion molecule-1 (VCAM-1) plays important roles

265 lular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin, resul

266 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), are expressed.

267 chemoattractant protein-1 (MCP-1), vascular cell adhesion molecule-1 (VCAM-1), nuclear factor kappaB

268 subsequent induction of endothelial vascular cell adhesion molecule-1 (VCAM-1), which is required for

269 y late antigen-4 (VLA-4) binding to vascular cell adhesion molecule-1 (VCAM-1), which is upregulated

270 onsequence of reduced expression of vascular cell adhesion molecule-1 (VCAM-1), which regulates leuko

271 in-1 (MCP-1) and 36% lower lesional vascular cell adhesion molecule-1 (VCAM-1).

272 underwent firm adhesion mediated by vascular cell adhesion molecule-1 (VCAM-1).

273 that enables imaging of endothelial vascular cell adhesion molecule-1 (VCAM-1).

274 ry activation involving exposure of vascular cell adhesion molecule-1 (VCAM-1).

275 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

276 ar adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

277 kines, and cell adhesion molecules (vascular cell adhesion molecule 1 [VCAM-1] and intracellular adhe

278 ibitor of metalloproteinases 1; and vascular cell adhesion molecule 1 [VCAM-1]) were measured by usin

279 t induction of the pro-inflammatory vascular cell adhesion molecule 1 (VCAM1) cell-adhesion protein.

280 profile with focal upregulation of vascular cell adhesion molecule 1 (VCAM1), a protein that facilit

281 ellular adhesion molecule 1 (ICAM1)/vascular cell adhesion molecule 1 (VCAM1), whose expression was a

282 of the proinflammatory cell surface vascular cell adhesion molecule 1 (VCAM1).

283 , which was reversed by blockade of vascular cell adhesion molecule-1 (VCAM1) and very late antigen-4

284 Vascular cell adhesion molecule-1 (VCAM1) constitutes a relevant

285 subunit on myeloma cells stimulated vascular cell adhesion molecule-1 (VCAM1) on MSCs, leading to the

286 the adhesion and signaling molecule vascular cell adhesion molecule-1 (VCAM1).

287 responsive genes, but expression of vascular cell-adhesion molecule-1 (Vcam1) was particularly high.

288 r endothelial growth factor [VEGF], vascular cell adhesion molecule 1 [VCAM1], and GTP binding protei

289 Although vascular cell adhesion molecule-1 (VLA-4 receptor) was expressed

290 : 1.30 mmol/L; P = 0.021), and intercellular cell adhesion molecule-1 (WA: 153.9 ng/mL; CB: 159.4 ng/

291 cle cell actin, and upregulation of vascular cell adhesion molecule-1 was also suppressed in FLAP kno

292 ercellular adhesion molecule 1, and vascular cell adhesion molecule 1) was slightly up- or down-regul

293 le, CD31, also known as platelet endothelial cell adhesion molecule-1, was sialylated via alpha2,6-li

294 esion receptor PECAM-1 (platelet endothelial cell adhesion molecule-1), we investigated a potential c

295 lar adhesion molecule 1 and soluble vascular cell adhesion molecule 1 were reduced after whey protein

296 othelial growth factor, and soluble vascular cell adhesion molecule-1 were associated with DFU healin

297 ocyte chemoattractant protein-1 and vascular cell adhesion molecule-1 were reduced.

298 tracellular adhesion molecule-1 and vascular cell adhesion molecule-1, which caused a fourfold increa

299 oparticles positive for platelet-endothelial cell adhesion molecule-1, which could serve as potential

300 monocytes sheared in whole blood on vascular cell adhesion molecule-1, while characterizing adhesion